Orexigen Therapeutics, Inc. Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Orexigen Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Orexigen Therapeutics, Inc. for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 04 2016 | OREX | Orexigen Therapeut ... | Moglia Stephen A. | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 90,000 | 0 | 90,000 | |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | Moglia Stephen A. | VP, Chief Accountin ... | Option Exercise | A | 1.78 | 65,000 | 115,700 | 65,000 | |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | ACE HEATHER S | EVP, Global Human R ... | Option Exercise | A | 0.00 | 225,000 | 0 | 225,000 | |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | Lynch Thomas P. | EVP. General Counse ... | Option Exercise | A | 0.00 | 255,000 | 0 | 255,000 | |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | Klassen Preston | EVP, Global Develop ... | Option Exercise | A | 0.00 | 350,000 | 0 | 350,000 | |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | Klassen Preston | EVP, Global Develop ... | Option Exercise | A | 1.78 | 190,000 | 338,200 | 190,000 | |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | Klassen Preston | EVP, Global Develop ... | Grant | A | 2.03 | 4,170 | 8,465 | 10,160 | 6 K to 10.2 K (+69.62 %) |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | Klassen Preston | EVP, Global Develop ... | Grant | A | 4.17 | 1,860 | 7,756 | 5,990 | 4.1 K to 6 K (+45.04 %) |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 350,000 | 0 | 350,000 | |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Option Exercise | A | 1.78 | 390,000 | 694,200 | 390,000 | |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Grant | A | 2.03 | 5,091 | 10,335 | 5,091 | 0 to 5.1 K |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 0.00 | 800,000 | 0 | 800,000 | |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 1.78 | 700,000 | 1,246,000 | 700,000 | |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Grant | A | 2.03 | 1,761 | 3,575 | 60,508 | 58.7 K to 60.5 K (+3.00 %) |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Grant | A | 4.17 | 721 | 3,007 | 58,747 | 58 K to 58.7 K (+1.24 %) |
| Feb 04 2016 | OREX | Orexigen Therapeut ... | ACE HEATHER S | EVP, Global Human R ... | Option Exercise | A | 1.57 | 325,000 | 510,250 | 325,000 |